GlassScriptPhysician profile
Collette G Brown
NPI 1003427899
$10,583.08
in general payments reported to CMS, 2019-2025
45 companies · $1,987 in 2025
The $1,987 reported for 2025 was more than what 93% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,736 · 2022: $1,895 · 2023: $3,303 · 2024: $1,661 · 2025: $1,987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,854 · Travel and Lodging: $1,080 · Education: $17.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,854.43 |
| Travel and Lodging | $1,080.01 |
| Education | $17.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,054.25 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Novo Nordisk INC | $1,060.63 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $856.97 | 2021-2025 | Mounjaro, Zepbound, Humulin |
| Corcept Therapeutics | $670.77 | 2021-2025 | Korlym |
| Dexcom, INC. | $614.21 | 2021-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $559.08 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Sanofi-Aventis U.S. LLC | $444.79 | 2022-2025 | |
| Insulet Corporation | $441.60 | 2021-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $394.83 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $392.32 | 2021-2025 | Tepezza, Evenity, Prolia |
| Recordati_rare_diseases_inc. | $343.97 | 2021-2025 | Isturisa, Signifor Lar |
| Amarin Pharma, INC. | $259.15 | 2021-2022 | |
| Antares Pharma, INC. | $228.22 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Radius Health, INC. | $183.87 | 2021-2025 | Tymlos |
| Currax Pharmaceuticals LLC | $171.90 | 2021-2023 | Contrave |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $167.06 | 2021-2025 | |
| Abbvie INC. | $157.44 | 2023-2025 | |
| Horizon Therapeutics Plc | $141.15 | 2022-2023 | Tepezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.50 | 2021-2025 | Jardiance |
| Ibsa Pharma INC. | $108.39 | 2021-2025 | Tirosint, Licart, Licart |
| Nevro Corp. | $99.17 | 2022-2023 | Senza |
| Ascendis Pharma Endocrinology INC | $97.86 | 2023-2025 | Yorvipath |
| Kowa Pharmaceuticals America, INC. | $86.18 | 2021-2023 | Livalo, Seglentis |
| Merck Sharp & Dohme LLC | $81.60 | 2021-2022 | |
| Grt US Holding, INC. | $78.82 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $78.61 | 2021-2022 | |
| Sequel Med Tech, LLC | $78.18 | 2025 | Twiist |
| Kyowa Kirin, INC. | $74.53 | 2023-2024 | Crysvita |
| Acella Pharmaceuticals, LLC | $65.90 | 2024-2025 | NP Thyroid 60 |
| Averitas Pharma INC. | $62.63 | 2024 | Qutenza |
| Regeneron Healthcare Solutions, INC. | $59.96 | 2025 | Evkeeza |
| Amryt Pharma Holdings LTD | $39.96 | 2022-2023 | Mycapssa |
| Pfizer INC. | $37.14 | 2024-2025 | |
| Clarus Therapeutics INC. | $31.72 | 2021 | |
| Madrigal Pharmaceuticals | $31.63 | 2025 | Rezdiffra |
| Cequr Corporation | $30.11 | 2025 | Cequr Simplicity |
| Halozyme INC | $24.71 | 2023 | |
| Beta Bionics, INC. | $20.17 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Esperion Therapeutics, INC. | $19.05 | 2022 | |
| Opko Pharmaceuticals, LLC | $17.48 | 2023 | Rayaldee |
| Eusa Pharma (US) LLC | $17.31 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $17.01 | 2025 | Imcivree |
| Alexion Pharmaceuticals, INC. | $16.98 | 2025 | Strensiq |
| Vifor Pharma, INC. | $16.92 | 2021 | |
| Zealand Pharma US, INC. | $13.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collette Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.